Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details) - Schedule of stock-based compensation expense

v3.21.2
Stockholders' Equity (Details) - Schedule of stock-based compensation expense - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Schedule of stock-based compensation expense [Abstract]    
Research and Development $ 1,232 $ 1,014
General and Administrative 1,116 1,013
Total $ 2,348 $ 2,027